TOKYO: Japan’s health ministry has approved one of the world’s first blood test kits to detect signs of Alzheimer’s disease, paving way for a simpler and speedier diagnosis of the brain-wasting ailment for which a blockbuster therapy is finally on the horizon.
The diagnostic product developed by Kobe-based Sysmex Corp measures amyloid beta — an abnormal protein that jams nerve cells in the brain and is a marker of Alzheimer’s.
